A 68-year-old woman with HER2-negative, hormone receptor-positive invasive ductal carcinoma of the breast undergoes a modified radical mastectomy and is referred for adjuvant chemotherapy, including doxorubicin and cyclophosphamide followed by paclitaxel. What is the primary mechanism of action of doxorubicin?